)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
Devyser Diagnostics (DVYSR) investor relations material
Devyser Diagnostics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary22 Jul, 2025
Executive summary
Achieved record quarterly revenue of SEK 67.4 million, up 26.6% year-over-year, with gross margin at 84.2% and EBIT at SEK 5.5 million, including SEK 1.8 million in one-off reorganization costs.
Completed reorganization and cost control initiatives, resulting in a healthier cost structure and improved efficiency without compromising growth.
Launched three new products: HLA Loss, Genomic Blood Typing, and RHD IVDR, receiving positive customer feedback and early orders.
Strong commercial momentum in EMEA and North America, with US revenue growing over 200% quarter-over-quarter.
Confident in achieving 30% annual organic growth, 80% gross margin, and 20% EBIT margin by 2026.
Financial highlights
Revenue for Q2 2025 was SEK 67.4 million, up from SEK 53.2 million in Q2 2024, marking a 26.6% increase.
Gross margin reached 84.2%, benefiting from new facilities, sales growth, and reorganization savings.
EBIT was SEK 5.5 million, a turnaround from SEK -22.7 million last year, including SEK 1.8 million in one-off costs.
Cash position at quarter-end was SEK 100.4 million, with no debts.
Q2 EPS SEK 0.08 (vs. SEK -1.41); H1 EPS SEK -1.16 (vs. SEK -2.15).
Outlook and guidance
Expecting continued strong growth, with a healthy sales funnel and new product launches supporting momentum.
Confident in reaching financial targets of 30% annual organic growth, 80% gross margin, and 20% EBIT margin by 2026.
Revenue build-up expected to increase quarter by quarter, especially through Thermo Fisher partnership.
Awaiting MolDx reimbursement decision for US CLIA-based test, expected to enable broader US commercialization later in 2025.
No further restructuring costs expected in H2; new cost base established.
Assess impact of cost cuts on 2026 targets.
Explain US commercialization of CLIA test.
How will tariffs impact costs and revenues?
What's the expected revenue trend with Thermo?
OpEx growth rate expectations for 2026?
Detail the HLA loss product's positive feedback.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Devyser Diagnostics earnings date
Q3 20256 Nov, 2025
Next Devyser Diagnostics earnings date
Q3 20256 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
)
Edge19 Sep 2025
American Express: An Empire of Plastic
How history, brand, and structure have steadily built American Express' moat, and why Warren Buffett still calls it a one-of-a-kind business.
Frequently asked questions
Devyser Diagnostics AB is a Swedish company that develops, manufactures, and sells advanced diagnostic kits for DNA testing. Their products are primarily used in the fields of hereditary diseases, oncology, and post-transplantation monitoring. These diagnostic solutions enable laboratories to conduct complex genetic tests, including those for cancer treatments, prenatal screening, and transplant patient follow-ups. The company also provides software tools for data analysis and interpretation to support their test kits. The company is headquartered in Stockholm, Sweden, and its shares are traded on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage